Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRB2 | P62993 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 14/20 | 0.33 |
| ▸ | FNTB | P49356 | 14/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 13/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | GNPAT | O15228 | 1/20 | 0.32 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.32 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30811175 | 0.91 | FNTA (0.34) | GRB2FNTAFNTBPGGT1BKISS1R | |
| SCHEMBL30811162 | 0.90 | NPY4R (0.37) | GRB2FNTAFNTBPGGT1BIL23R | |
| SCHEMBL30811168 | 0.89 | FNTA (0.33) | FNTAFNTBPGGT1BIL23RKISS1R | |
| SCHEMBL30811122 | 0.89 | IL23R (0.38) | FNTAFNTBPGGT1BIL23R | |
| SCHEMBL30811153 | 0.83 | NPY4R (0.34) | FNTAFNTBPGGT1BIL23RKISS1R | |
| SCHEMBL32690413 | 0.83 | NPY4R (0.39) | IL23R | |
| SCHEMBL30811179 | 0.82 | IL23R (0.41) | IL23R | |
| SCHEMBL32690442 | 0.82 | IL23R (0.39) | IL23R | |
| SCHEMBL30811150 | 0.81 | SIRT5 (0.39) | FNTAFNTBPGGT1BIL23R | |
| SCHEMBL30811146 | 0.81 | NPY4R (0.38) | FNTAFNTBPGGT1BIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083865-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | KLK3, FOLH1, PSMA1 | GRB2 1753/4885FNTA 1407/4885FNTB 338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.